Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection
Bo Langhoff Hønge(Aarhus University Hospital), Christian Erikstrup(Aarhus University Hospital), Anna Christine Nilsson(Odense University Hospital), Susan Mikkelsen(Aarhus University Hospital), Henrik Ullum(Statens Serum Institut), Erik Sørensen(Copenhagen University Hospital), Henrik Hjalgrim(Copenhagen University Hospital), Ole Birger Pedersen(University of Copenhagen), Dorte Kinggaard Holm(Odense University Hospital), Sisse Rye Ostrowski(University of Copenhagen), Kathrine Agergård Kaspersen(Aarhus University Hospital), Tyra Grove Krause(Statens Serum Institut), Bitten Aagaard(Rigshospitalet), Charlotte Sværke Jørgensen(Statens Serum Institut), Susanne Gjørup Sækmose(Zealand University Hospital), Lene Holm Harritshøj(University of Copenhagen), Lotte Hindhede(Aarhus University Hospital)
Cited by 17
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles
|Nature Genetics|2022|396
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
|International Journal of Epidemiology|2020|280
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
|The Lancet Infectious Diseases|2022|218